Staphylococcus aureus is one of the first pathogens, which often persistently infects the airways of cystic fibrosis (CF) patients. Nasal S. aureus carriage is a risk factor for S. aureus infections in non-CF patients. Topical treatment strategies successfully eradicated nasal S. aureus carriage thereby decreasing S. aureus infection. A prospective longitudinal multicenter study was conducted to assess whether nasal carriage represents a risk factor for S. aureus colonization of the oropharynx in young CF patients. Cross sectional analysis aureus infection and persistence. Hence, it is unlikely that CF patients will benefit from topical treatment strategies to eradicate nasal carriage. 
INTRODUCTION

Cystic fibrosis (CF) is one of the most prevalent hereditary diseases in the Caucasian
population. Although quality of life and life expectancy have increased during the last decades, more than 98% of the patients still suffer from chronic airway infections, and more than 95% of deaths are related to respiratory insufficiency (16) . One of the most common pathogens isolated from the airways of young CF patients is Staphylococcus aureus. Several longitudinal studies and data from CF registries revealed that S. aureus infection frequently starts in early infancy, preceding chronic Pseudomonas aeruginosa infection, which is characteristic for the advanced stages of the disease (5) . Once S. aureus infects the airways of CF patients, the bacteria are difficult to eradicate despite the use of appropriate antistaphylococcal therapy (10) . In many CF patients, the same S. aureus clone infects the airways for years and antibiotic therapy only suppresses the pathogen for a period of time giving rise to exacerbations requiring repeated courses of treatment (11, 19) . The anterior nares, from which S. aureus can be isolated most consistently, have been shown to present an ecological niche for this microorganism (20, 31 ) from where the bacteria can spread to other parts of the body (30). Interestingly, nasal S. aureus carriage has been shown to represent a risk factor for a number of S. aureus infections such as sternal wound infections in patients after cardiac surgery (15) , peritonitis in patients on continuous ambulatory peritoneal dialysis (22) and exit-site infections in hemodialysis patients (13) .
Studies observing the onset of S. aureus bacteremia demonstrated that acquisition of the pathogen occurred mostly via the endogenous route due to the patient's own flora rather than via external transmission (28).
Preventive strategies have been developed to eliminate nasal S. aureus carrier status by topical treatment with antibiotics (14) . If the anterior nares were treated locally, the organism also disappeared from other sites of the body in most cases (14) . Mupirocin, a 3
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on November 13, 2017 by guest http://jcm.asm.org/ Downloaded from natural antibiotic derived from P. fluorescens (8) , has been used in patients undergoing dialysis, orthopaedic or open heart surgery, revealing a significant reduction of S. aureus infections in patients treated topically compared to untreated patients (1, 3, 6, 12) .
If nasal carriage would be recognized as a risk factor for airway infection early in CF patients, the patients could benefit from topical antibiotic treatment. As of yet, there is no information about assessing the sequence of S. aureus infection in CF patients. Therefore, we conducted a prospective longitudinal multicenter study to determine whether nasal carriage represents a risk factor for S. aureus colonization of the oropharynx in young CF patients. 
MATERIALS AND METHODS
Study design
Four specialized CF clinics (two in Muenster, one each in Duesseldorf and Essen) participated in the study. There are basically three different strategies of treatment against S. aureus: The study consisted of 2 parts: 1. A cross-sectional part assessing the prevalence of nasal and oropharyngeal carriage in young CF children determined by analysis of the first specimens after recruitment (n=80). These data were compared to specimens of a control group from the Department of Ophthalmology comprising patients who underwent a short surgical procedure due to nasolacrimal duct obstruction (n=109).
2. A longitudinal part of the study analysing the sequence of infection in CF children, from which repeated specimens were available over a time period of at least 18 months (n=62). Nasal and oropharyngeal swabs or sputa of patients were taken during their regular (quarterly) visits to the outpatient clinics. To assess nasal carriage, the anterior 1.5 cm of the nasal vestibule of both the left and right nares was rubbed with a sterile cotton swab.
Ethical approval for the study was obtained from the institutional review boards of all participating centres, written informed parental consent was obtained in all cases.
Questionnaire
Parents were asked to answer a standardized questionnaire to determine risk factors for the acquisition of S. aureus carriage at recruitment. Information was obtained regarding 5 (14, 23, 29) . Additionally, the parents were asked if the children used stuffed animals, special favourite toys or contacted other CF patients. Additionally, specimens were cultured in dextrose broth to enrich bacterial growth and streaked on blood and endo agar after 48 h. Special culture conditions for the isolation of SCVs were used as described (10) . Briefly, primary cultures were streaked on BHI agar with 5% NaCl and on Schaedler agar, which is a rich medium agar, used to culture anaerobic bacteria, and incubated for 48h at 35ºC. Identification of S. aureus was
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Persistent carriage
The longitudinal part of the study allowed determining the carriage patterns of S. aureus in both the nose and the oropharynx. Three different colonization patterns for nasal carriage have been described in the literature: persistent carriage, intermittent carriage and non-carriage (29). Persistent carriage/colonization/infection was defined as having S. aureus positive cultures for at least 6 months based on a minimum of 2 positive cultures from the respective specimens taken at regular quarterly visits. 
Molecular typing
Isolates were analyzed by pulsed-field gel electrophoresis (PFGE) after SmaI restriction of whole chromosomal DNA (7). The gels were analyzed both visually and by the computer program Quantity One (Bio-Rad Laboratories, Hercules, Ca) and interpreted according to published guidelines (25,26). Consecutive isolates from the same patient, with identical or only minor differences in fragment patterns were assigned to the same clone or clonal lineage, if the Dice coefficient was higher than 85 % (26). Isolates with a similarity index beyond 85% were considered to belong to different clones.
Statistical analysis
Analysis of the S. aureus prevalence was carried out by standard statistical tests (median, Student's t-test, chi-square test). The Fisher's exact test was used to calculate the correlation of nasal and oropharyngeal carriage. To assess risk factors for S. aureus colonization Odds Ratios (OR) were calculated comparing cases with suitable controls. The bivariate analysis was followed by stratification and logistic regression analysis using SPSS Version 11.5. The probability of oropharyngeal carriage was significantly higher in nasal carriers than in non-carriers both in CF and controls (OR 6.2; CI 2.2 -17.0; p < 0.001 for CF: OR 7,9; CI 2.6 -23.6, p < 0.001). In contrast to the control group, who were colonized at both sites in similar frequency, the oropharynx was significantly more often colonized in CF children.
In our study population, the median acquisition age of S. aureus oropharyngeal and nasal colonization was 4.18 years and 4.45 years, respectively.
Dynamics of S. aureus infection in young CF children
Culture results from nasal and oropharyngeal specimens of 62 CF children (40 % girls) with a median age of 3.5 years, who were followed for at least 18 months, were and oropharyngeal cultures per patient were 9.5 and 11 specimens, respectively. S. aureus isolates were cultured from 196/587 (33%) nasal and 305/659 (46%) oropharyngeal swabs.
In 17 (27%) children, S. aureus was already cultured from the nose and airways at recruitment. In 29 (47%) children S. aureus colonization could be observed for the first time during the observation period: In 9 (14%) children, S. aureus was cultured at the same time from the nose and the oropharynx, in 14 (23%) patients only from the oropharynx at first and later also from the nose and in 6 children from the nose followed later by positive cultures from the oropharynx. The only site of S. aureus recovery during the study period was the oropharynx and the nose in 14 patients (23%) and in one patient (2%), respectively. Only one patient never carried S. aureus throughout the study period. In summary, during the longitudinal part of the study, S. aureus was cultured from the upper airways and the nose in 46 children, from the oropharynx only in 14 children and from the nose only in 1 patient (Fig. 2) . Thus, the most prevalent site for S. aureus in CF patients was the oropharynx (60/62; 97%) with a significant lower prevalence in the nose (47/62; 76%; p < 0.001). (Table 2) .
Persistent carriage of S. aureus in nose and oropharynx
Eighty-five of these clones were isolated from both sites (79% of the nasal clones; 55% of the oropharyngeal clones). Fourteen clones appeared first in the nares as exemplified for one patient in Fig. 3a , 31 in the oropharynx as shown for a second patient in Fig. 3b , whereas 40 clones were isolated from both sites at the same time as demonstrated for a third patient in Fig. 3c . Overall, the number of different and persisting clones was statistically significant higher in the oropharynx than in the nose (Table 2) . While nearly all clones isolated from the nose appeared either at the same time or later also in the oropharynx (82%), clones isolated from the oropharynx were less likely to be isolated from the anterior nares (57%). 
Susceptibility
Risk factors for S. aureus carriage
Forty-three questionnaires completed by parents of 29 boys and 14 girls were included for further analysis reflecting a response rate of 69%. The epidemiological and microbiological data of this subgroup were representative for the whole group: The median age of the children was 3.5 years, the median observation period 33 months. S. aureus was cultured from 142/434 (33%) nasal and 220/495 (44%) throat swabs. The use of a pacifier, oral or inhalative antibiotics, the regular attending of a children dare care center, hospital stay or using a stuffed animal were not associated with persistent S. aureus carriage at either site. However, in the logistic regression analysis having a pet at home was associated with nasal carriage (OR 4.5; CI 1.0 -21.1; p = 0.05). 
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DISCUSSION
The cross-sectional part of the study demonstrated that significantly more CF children harboured S. aureus in both their anterior nares and oropharynx than the control group. The carrier rate of our control group is consistent with the study by Peacock et al., in which 21% of children followed from birth were colonized at the age of 6 months (18). Our data indicate that CF by itself represents a risk factor for S. aureus acquisition and thus also infection.
While the control group had similar carriage rates in the oropharynx and anterior nares, positive cultures of the oropharynx significantly exceeded carriage rates of the anterior nares in CF children. This finding is in contrast to many other studies as reviewed in (14), where the anterior nares were the main site for S. aureus colonization in humans. The high rate of S. aureus detection in this study underscores the fact that S. aureus is acquired very early in CF patients. It is conceivable that the recruited group with a median age of 3.6 years may have already been too old to follow the sequence and the acquisition age of S. aureus. Interestingly, the acquisition age of S. aureus colonization in the oropharynx and in the nose in the investigated study population was 4.14 and 4.48 years, respectively. However, studying infants diagnosed by neonatal screening may potentially yield different results with a lower S. aureus acquisition age and another sequence of S. aureus colonization. It is also possible that the sampling interval at the quarterly clinic visits with a relatively low sampling frequency may have led to a lower detection rate of nasal carriage preceding oropharyngeal carriage. However, a very short transient period of nasal carriage would not be clinically relevant, since this could not be addressed with a topical treatment strategy. The S. aureus prevalence in the nose was higher in CF patients than in the control group. However, the S. aureus prevalence in the nose was exceeded by the prevalence in the oropharynx in CF patients. This may be explained by additional changes present in the airways such as the impaired mucociliary clearance or changed presentation of receptors for bacterial binding present on epithelial cells (9) . It may also be due to expectoration of lower airway secretions containing S. aureus through the oropharynx. Interestingly, a recent study in non CF patients and hospital personnel also reported a higher frequency of oropharyngeal colonization compared to the nares albeit in less bacterial numbers (17) . These results are in contrast to other published studies so far, but raise the question whether differences in culture technique may affect the detection rate of S. aureus. Furthermore, the fact that in this study the tonsils, which have been shown to be a source for recurrent S. aureus carriage in some cases (27), and not the oropharynx were swabbed, may have resulted in this high S. aureus prevalence in the throat. Since most young CF children do not produce sputum, most of the specimens that we investigated were oropharyngeal swabs. It has been shown that oropharyngeal cultures represent good negative but not good positive predictive values for bacteria present in the lower airways (21) . Therefore, it is difficult to draw conclusions about the number of patients with S. aureus infections in the lower airways. To do so, it would have been necessary to study bacterial cultures of bronchoalveolar lavage fluid, a method which would have been too unsuitable for repetitive clinical use in children. However, it was not the intention of our study to determine the rate of S. aureus infection in CF patients but rather to study the sequence of S. aureus colonization.
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The results of our study have implications for treatment strategies for CF patients. Our data identified the oropharynx as the most prevalent and often the first site of S. aureus carriage in young CF patients. Treatment strategies to prevent infections by eradication of nasal carriage will therefore not be an option for CF patients. Our data may also be transferred to the management of MRSA eradication in CF. In non CF patients,
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A C C E P T E D on November 13, 2017 by guest http://jcm.asm.org/ Downloaded from MRSA eradication procedures usually combine nasal eradication with the topical use of antiseptics leading in most cases to the loss of the pathogen. However, considering the high prevalence of S. aureus in the upper airways, it is very unlikely that MRSA in CF patients will be eradicated by standard hygiene procedures.
In conclusion, our findings demonstrate that CF patients carried S. aureus mostly in their oropharynx and not in the nose which is in contrast to other patient groups and healthy individuals. Furthermore, persistent carriage rates were higher in the oropharynx than in the nose. Therefore, it is highly unlikely that CF patients will benefit from local eradication strategies of nasal carriage to prevent S. aureus airway infections. 1 Mean number of clones isolated from individual patients during the study period; (range) 2 Clones, which persisted >/= 6 months *statistically significant (p<0.05) 3 mean persistence of clones in months 4 isolated only at a single occasion Table 2 
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